RecruitingNot ApplicableNCT05370287

Adaptive Optics Retinal Imaging


Sponsor

Food and Drug Administration (FDA)

Enrollment

80 participants

Start Date

Jan 22, 2018

Study Type

INTERVENTIONAL

Conditions

Summary

The objective of the study is to collect and assess adaptive optics (AO) retinal images from human subjects in support of projects to demonstrate, advance, and enhance clinical use of AO technology.


Eligibility

Min Age: 21 Years

Plain Language Summary

Simplified for easier understanding

This study is using a high-resolution eye imaging technique called adaptive optics retinal imaging to photograph individual cells in the back of the eye. Researchers want to study how the retina changes in people with open-angle glaucoma (a condition where elevated eye pressure damages the optic nerve) compared to people with normal vision. **You may be eligible if...** - You are 21 or older - You can follow simple instructions and cooperate with the imaging process (similar to a routine eye exam) - You have been diagnosed with primary open-angle glaucoma (POAG) — for the glaucoma group - OR you have normal eyes and vision — for the comparison group **You may NOT be eligible if...** - You are under 21 - You have a vision condition that prevents clear imaging (such as unstable fixation or very cloudy eye media) - Your prescription is outside the range of –8 to +4 diopters - You have had a bad reaction to eye-dilating drops before - You have narrow angles or a history of acute angle-closure glaucoma - You have lung disease like COPD or asthma (for the oxygen challenge portion only) - You tested positive for COVID-19 at enrollment or have chronic light sensitivity from it Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERoxygen inhalation

Subjects will breath 100% oxygen through a mask.

DEVICEAdaptive optics imaging

Adaptive optics scanning laser ophthalmoscopy (AOSLO) and adaptive optics - optical coherence tomography (AO-OCT) retinal imaging


Locations(1)

Food and Drug Administration

Silver Spring, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05370287


Related Trials